According to this study, five compounds (methyl-3,1-benzoxazin-4-one 
Quinazolinone derivatives have been reported to be biologically versatile compounds possessing variety of activity including anticonvulsant property. In 1999, Santagati et al., synthesized methaqualone as a sedative hypnotic, which consequently represented an important landmark in the field of synthetic anticonvulsant (Hazarkhani and Karimi (2003) , Weber et al., (2003) , Liu et al., (2005 , Archana et al., (2004) , Watkins et al., (2007) and Connolly et al., (2005) ). However, pteridinone exhibited several pharmacological actions (Grover et al., 2005) , anti-histaminic (Zhang et al., 2007) , anti-allergic (Kamal et al., 2006) and anti-hypertensive (de et al., 2005) . In view of the above considerations and aiming to locate novel anticonvulsants, we reported the synthesis of the title compounds in which the two moieties were joined in one molecule by applying Mannich reaction on the active methylene. Remarkable anticonvulsant properties were observed by most of the tested compounds.
Experimental Protocol Chemistry

Melting points were recorded in open capillaries on Gallenkamp hot stage or Reichert
Hot stage microscope and were uncorrected. Infrared (IR) spectra were measured with Perkin-Elmer, FT-IR Spectrometer, using potassium bromide and results are given as per centimetre (/cm). NMR spectra were recorded in CDCl 3 , CD 3 OD, DMSO-d 6 on JEOL-NMR 400 MHz spectrometer. The chemical shifts are reported in parts per million (ppm) downfield from tetramethylsilane. Electron impact MS spectra were obtained on MAT-711 spectrometer, inlet temp 200, ionization energy 70 eV. Mass spectra were run on Hewlett Packard 5988 spectrometer, some reactions under microwave irradiation model Galanz Microwave Oven WP 1000AL23. The progress of all reactions was monitored by TLC on TLC sheet, silica gel 60 F 254 layer thickness 0.2 mm (5 × 10 cm) and TLC plates pre-coated silica gel 60 (20 × 20 cm). T h e d e v e l o p e d c h r o m a t o g r a m s w e r e viewed under ultraviolet light. Column chromatography was performed on silica gel 0.13-0.25 mm (60-120) mesh and Sephadex LH-20 µm (25-100).
from acetic anhydride. The physical property is shown in Table 1 .
Method (2)
A mixture of anthranilic acid (4.11 g, 0.03 mol) and acetic anhydride (0.1 mol) was irradiated at power input (60 W), the reaction was monitored by TLC till completion. The product was washed with petroleum ether (40-60°C). The physical data are shown in Table 1 .
3-Amino-2-methyl-3H-quinazolin-4-one (II) 2-Methyl-3,1-benzoxazin-4-one (I) (1.61 g, 0.01mol), hydrazine hydrate 99% (0.01 mol) ware heated under reflux in EtOH (30 ml) (4 h) until completion TLC monitoring (CHCl 3 :EtOH) (7:3). The reaction mixture was filtered while hot and the product compounds (II) (III) and (IV) were isolated by (TLC). The physical and spectral data are shown in Tables 1-4 .
3-(4-Aminophenyl)-2-methyl-3H-quinazolin-4-one (V)
Method (1) 2-Methyl-3,1-benzoxazin-4-one (I) (1.61 g, 0.1 mol) and p-phenylenediamine (1.08 g, 0.1 mol) were heated under reflux in dry pyridine for 8 h. The reaction was cooled and treated with acidic ice water (10% hydrochloric acid). The separated solid was washed with water and then crystallized from ethanol.
Method (2)
2-Methyl-3,1-benzoxazin-4-one (I) (1.61 g, 0.1 mol), p-phenylenediamine (1.08 g, 0.1 mol) and acetic acid (50 ml) were heated under reflux in oil bath for 4 h. The reaction mixture was filtered and re-crystallized from ethanol.
Method (3)
A m i x t u r e o f a n t h r a n i l i c a c i d ( 1 . 3 7 g , 0 . 1 m o l ) p-phenylenediamine (1.08 g, 0.1 mol) acetic anhydride (1.05 ml) was irradiated at power input (600 W) for (6 min). The physical and spectral data are shown in Tables 1-4 .
2-Methyl-3-{4-[(3-methyl-5 -oxo-1-phenyl-4,5-dihy dro-1H-pyr azol-4-ylme thyl)-amino]-phenyl}-3H-quina olin-4-one (VI)
A solution of 3-methyl-1-phenyl-pyrazol-5-one (1.74 g, 0.01 mol), compound V and formaldehyde (0.02 mol) in EtOH (60 ml) was refluxed for 11 h, and then evaporated under reduced pressure. The product was filtered off, washed with n-hexane and purified after separation by column chromatography (CHCl 3 : EtOH) (9:1). The physical and spectral data are shown in Tables 1-4 .
3-Amino-2-mercapto-3H-quinazolin-4-one (VII)
To a vigorously stirred solution of methyl anthranilate (1.51 g, 0.02 mol) in dimethylsolfoxide (10 ml) at room temperature, carbon disulphide (1.6 ml) and aqueous sodium hydroxide (1.2 ml) was added drop wise with stirring for 1 h. Dimethyl sulphate (0.02 mol) was added drop wise with cooling in an ice bath. Stirring was continued for 3 h, the reaction mixture was poured into ice-water and then extracted with chloroform. The solvent was removed by distillation under reduced pressure. The obtained dithiocarbamate was used without purification. Hydrazine hydrate (0.2 mol) was added drop wise to stirred dithiocarbamate (0.02 mol) in cold condition. After adding, stirring was continued for 2 h at 50°C and the mixture was poured into ice-water. The solid obtained was filtered, washed with water, dried and purified by column chromatography (EtOH: n-Hexane: CHCl 3 ) (4:3:3). The physical and spectral data are shown in Tables 1 and 2 .
5-[(2-Mercapto-4-oxoquinazolin-3 (4H)-ylamino) methyl]-2-thiobarbituric acid (IX)
To a solution of thiobarbituric acid (1.44 g, 0.1 mol) in ethanol, compound VII and formaldehyde (0.02 mol) in ethanol (60 ml) was added. The reaction mixture was refluxed for 7 h then evaporated under reduced pressure. The product was filtered off, washed with methanol and purified after separation by (TLC) (EtOH: n-Hexane: CHCl 3 ) (4:3:3). The physical and spectral data are shown in Tables 1 and 2 .
5-[(2-Isopropyl-4-oxoquinazolin-3 (4H)-ylamino) methyl]-barbituric acid (XI)
A mixture of 3-amino-2-isopropyl-4-oxoquinazoline (X) (1 mmol), barbituric acid (1 mmol), formaldehyde (3 mmol) and acetic acid (1 mol) was irradiated for 5 min in a microwave oven at medium power. After cooling, the reaction mixture was poured onto crushed ice (40 g) and stirred for 5-10 min. The separated solid was filtered, washed with water dried and crystallized. The physical and spectral data are shown in Tables 1 and 4. 2-Isopropyl-3-[(3-methyl-5-oxo-1-phe nyl -4,5-dihydro-1H-pyr azol-4-yl) methylamino]-4-oxo-3Hquinazoline 2 (XII) A mixture of compound (X) (1 mol), 3-methyl-1-phenylpyrazol-5-one (1 mol) formaldehyde (3 mol) and acetic acid (1 mol) was irradiated in a microwave oven at medium power. After cooling, the separated solid was filtered washed with water and purified by column chromatography (CHCl 3 : Benzene: EtOH) (7:2:1). Physical and spectral data are shown in Tables 1 and 4. 
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5-[(2-Isopropyl-4-oxoquinazolin-3 (4H)-ylamino) methyl)-2-thiobarbituric acid (XIII)
A mixture of 3-amino-2-isopropyl-4oxo-3H-quinazoline (X) (1 mmol), thiobarbituric acid (1 mmol), formaldehyde (3 mmol) and acetic acid (1 mmol) was irradiated in a microwave oven of medium power for 1 min. After cooling, the separated solid was filtered washed with water and dried. The physical and spectral data are shown in Tables 1 and 4 . Tables 1 and 4 .
2-[(2-
2-Phenyl-4-(2,4,5-trimethoxy-benzylidene)-4H-oxazol-5-one (XV)
A m i x t u r e o f b e n z o y l g l y c i n e ( 0 . 0 1 m o l ) , 2,4,5-trimethoxybenzaldehyde (0.01 mol) and sodium acetate (0.006 mol) in acetic anhydride (20 ml) was heated in a boiling water bath for 8 h., the crystalline product obtained on cooling was filtered, washed with water and crystallized from acetic acid. Physical and spectral data are shown in Tables 1, 5 
Method 2
A m i x t u r e o f t h e a p p r o p r i a t e 2 -p h e n y l -4 -(2,4,5-trimet hoxy-benzylidene)-4H-oxa zol-5-one (XV) (0.01 mol) and methyl anthranilate (0.01 mol) in glacial acetic acid (5 ml) containing freshly fused sodium acetate (0.003 mol) was heated in water bath with continuous stirring for 3 h. The product was isolated after separation by column chromatography using sephadex LH-20. The physical and spectral data are shown in Tables 1, 5 and 6.
Methyl 5-bromo-2-[5-oxo-2-phenyl-4-(2,4,5-trimetho xybenzylidene)-4,5-dihydro-imidazol-1-yl] benzoic acid. (XVIb)
Method 1 A m i x t u r e o f ( X V ) ( 0 . 0 1 m o l ) a n d m e t h y l 5-bromo-anthranilate (0.01 mol) was fused in dry condition for 6 h. The product was then washed with ethanol and crystallized from dioxane. The physical and spectral data are shown in Tables 1 and 6 .
Method 2
A m i x t u r e o f ( X V ) ( 0 . 0 1 m o l ) a n d m e t h y l 5-bromoanthranilate (0.01 mol) in glacial acetic acid (5 ml) containing freshly prepared fused sodium acetate (0.003 mol) was heated in boiling water bath with continuous stirring for 8 h then washed with ethanol. Physical and spectral data are shown in Tables 1 and 6 .
2-Methyl-pyrazino [2,3-d][1,3]oxazin-4-one (XVIII)
A m i x t u r e o f a c e t i c a n h y d r i d e ( 5 0 m l ) a n d 3-aminopyrazino-2-carboxylic acid (0.03 mol) was refluxed for 25 min. The solvent was then removed and the obtained solid was filtered, washed and crystallized from acetic acid. The physical is shown Table 1 .
3-(4-Aminophenyl) -2-methyl-3H-pteridinone (XIX)
]ox azin-4-one (XVIII) (0.1 mol) and p-phenyle nediamine (0.1 mol) were heated under reflux in dry pyridine for 8 h. The reaction was cooled and treated with cold 10% hydrochloric acid. The separated solid was washed with water and crystallized from ethanol. The physical and spectral data are shown in Tables 1, 7 and 8. 4-(2-methyl-4-oxopteridin-3 (4H)-yl) phenylamino) methyl)-cyclohexane-1,3-dione (XXI) A mixture of 5,5-dimethyl-1,3-cyclohexanedione (0.01 mol), compound 3-(4-amino-phenyl)-2-methyl-3H-pteridin-4-one (XIX) and formaldehyde (0.02 mol) in MeOH (60 ml) was warmed for 30 h. The solvent was then removed under reduced pressure. The product was filtered off, washed with n-hexane purified by column chromatography. The spectral data are shown in Tables 1, 7 and 8.
5,5-Dimethyl-2-((
Pharmacology
Animals
Swiss albino mice (27-30 g birth Weight (bw)) of either sex were used throughout this study. Animals were maintained under standard conditions of temperature (23 ± 1.0°C), humidity (55 ± 10%), and light (approximately 12/12 h light/ dark cycle) and fed on standard pellet diet with water ad libitum. Unnecessary disturbance of animals is avoided. The dose of each chemical compound was calculated accurately. Animals were allowed to adapt to the laboratory environment for 1 week before experimentation. All procedures were carried out in accordance with the Institutional Ethical Committee approval.
Preparation of the tested chemical compounds
All the tested chemicals and the reference drug (diazepam) were dissolved in 2% v/v DMSO before oral administration to the experimental animals.
Acute toxicity experiment
Mice in groups of six were given the tested compounds orally in graded doses (50-4000 mg/kg bw). Control animals received the vehicle (2% v/v DMSO) and kept under the same conditions without any treatment. Toxic symptoms and number of mice, which died in each group, were recorded after 48 h observation.
Doses
In this investigation, an experimental dose of 100 mg/kg that equal to one-tenth LD 50 of most of the test compounds were selected to be given orally to mice. The reference drug, diazepam, was given orally at a certain dose (7.5 mg/kg). This dose was calculated by converting the therapeutic dose that used in human to mouse's dose according to the table of Paget and Barnes (1964) .
Anticonvulsant activity
All the test compounds were screened for their anticonvulsant activity in Swiss albino mice by using two seizure models; Strychnine-induced convulsion test and the maximal electroshock seizure (MES) test.
Strychnine-induced convulsion test
Strychnine-induced convulsion test was carried out as described by Kaputlua and Uzbay (2009) . Sixty-six mice were divided into 11 groups of 6 animals each. Mice of the first (normal control) and second (strychnine control) groups were treated orally with the vehicle in a dose of 5 mL/ kg. Mice of the third group (reference) were treated orally with the diazepam in a dose of 7.5 mg/kg. Animals of the 4 th to 11 th groups were orally given the test compounds in a dose equal to one-tenth their LD 50 (100 mg/kg). One hour post-medication, mice of groups 2-11 were injected IP with strychnine nitrate in a dose of 2.5 mg/kg and observed for the onset of tonic hind-limb extension. The ability of the test compounds to prevent this feature or delay the onset of hind-limb extension was considered as an indication of anticonvulsant activity.
Maximum electroshock seizure test
MES test was performed in mice as described by Loscher et al. (1984) . Sixty mice were divided into 10 groups and medicated orally with diazepam and the test compounds as those in strychnine-induced convulsion test (except the 2 nd group). One hour after medication, mice were subjected to different levels of an alternating electrical current by Ugo Basile convulsiometer (Pulse generator 57800-001), through ear clip electrodes for 0.2 s. The mean threshold electrical current that induced tonic hind-limb extensor seizure was determined in each group.
Statistical analysis
Data were expressed as mean ± SEM with n indicating the number of replicates for a given experiment. Data were analyzed by one-way analysis of variance (ANOVA) followed by Dunnett's post-hoc test for multiple comparisons. Results were considered significant at P < 0.05.
Results and Discussion
Chemistry
The synthetic strategy to obtain the target compounds (I-XXI) i s i l l u s t r a t e d i n s c h e m e s ( I -V ) . 2 -M e t h y l -1 , 3-benzaoxazin-4-one (I), was obtained through reaction of anthranilic acid with acetic anhydride by heating under reflux or applying microwave irradiation, which was further reacted with NH 2 NH 2 .H 2 O to produce compound (II). Compounds (III) and (IV) were isolated after purification by column chromatography.
Compound (V) was obtained by three methods; the first two methods were by condensation of compound (I) with p-phenylinediamine in presence of glacial acetic acid or dry pyridine. The third method was by microwave irradiation of anthranilic acid, p-phenylinediamine, acetic anhydride mixture.
Compound (VI) was synthesized using compound (V) with formaldehyde and 3-methyl-phenyl-pyrazol-5-one (Scheme 1).
Compound (VII) was prepared from the reaction of methyl anthranilate with CS 2 and NH 2 NH 2 .H 2 O. Compound (VIII) was obtained during the purification of compound (VII) using. Also compound (IX) was synthesized by reaction of (VII) with thiobarbituric acid and formaldehyde (Scheme 2). Compounds (XI-XIV) were prepared by reacting 3-amino-2-isopropyl-4 (3H) quinazolinone (X) with barbituric acid, thiobarbituric a c i d , 3 -m e t h y l -p h e n y l -p y r a z o l -5 -o n e a n d / o r 4,4-dimethyl-1,3-cyclohexanedione under Mannich reaction condition to yield compounds (XI-XIV), respectively (Scheme 3). U p o n t r e a t m e n t o f b e n z o y l g l y c i n e w i t h 2,4,5-trimethoxybenzaldehyde; compound (XV) was produced, which was further reacted with methyl anthranilate or 5-bromo analogue to produce compounds (XVIa, b) by fusion. Some unsuccessful trails were carried out to prepare compounds (XVIIa, b) via the reaction between compounds (XVIa, b) and NH 2 NH 2 .H 2 O (Scheme 4).
2-Methyl-pyrazino [2,3-d] [1,3]oxazin-4-one (XVIII) was obtained by refluxing of 3-amino-pyrazine-2-carboxylic acid and acetic anhydride. The latter compound was further reacted with p-phenylinediamine in presence of glacial acetic acid.
% free irradiation ofhod isd in each case of Pharmacy During purification of compound (XIX), compound (XX) was obtained. Unsuccessful attempts were carried out for preparation of compound (XIX) by reacting compound (XVIII) with p-phenylenediamine under microwave irradiation; in contrast. this compound was obtained successfully from the reaction of 3-amino-pyrazine-2-carboxylic acid, acetic anhydride and p-phenylinediamine under microwave irradiation. Furthermore, compound (XIX) was allowed to react with 5,5-dimethyl-1,3-cyclohexanedione (Dimedone) and formaldehyde to produce (XXI) (Scheme 5).
Pharmacology
Acute toxicity (LD50) test
The tested compounds are characterized by a low degree of toxicity. Oral administration of the new compounds in doses up to 200 mg/kg failed to kill any mouse within 48 h of observation. The calculated LD 50 of the tested chemicals in mice was found to be above 960 mg/kg. LD 50 of compounds 1 Ref, XII and XIII was 970 mg/kg. LD 50 of compounds II and III was 980 mg/kg. LD 50 of compounds VI, IX and XIV was 1000 mg/kg. Accordingly, the new synthesized compounds are considered safe since substances possessing LD 50 higher than 50 mg/kg are non-toxic (Buck et al., 1976) .
Anticonvulsant activity
No alteration in the latency to the onset of seizure induced by strychnine (2.5 mg/kg, i.p.) in the animals pre-treated with compounds II, VI and XIV in a dose of 100 mg/kg was observed [ Table 1 ]. Conversely, oral treatment of mice with compounds I Ref, III, IX, XII or XIII (100 mg/kg), 1 h before strychnine administration, alter the latency to the seizure onset when compared with the strychnine-treated group. They increased the latency (3.01, 1.84, 2.39, 3.26 and 2.55 times, respectively) to the onset of seizure induced by strychnine. In the electroshock investigation, the same compounds (I Ref, III, IX, XII and XIII) were found to be significantly active in mice [Tables 9 and 10]. They elevated the mean threshold electrical current required to induce tonic hind limb extensor seizure (7.5, 4.5, 5.5, 5.8 and 5.8 mA) in comparison to the control mice (3.0 mA).
